September 6, 2018 — Tafamidis is the first treatment to improve survival and reduce hospitalizations in a rare heart ...
Heart Failure
This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congestive heart failure (CHF). The channel includes news on HFpEF and HFrEF. Heart failure occurs when the heart is no longer able to pump as much blood as the body requires. This can lead to enlargement of the heart because the muscle works harder to supply blood, but the pumping is ineffective. This may be due to defects in the myocardium, such as an infarct, or due to structural issues such as severe valve regurgitation. The disease is divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant or a left ventricular assist device (LVAD).
August 13, 2018 — Congestive heart failure (CHF) is a terminal disease that affects nearly 6 million Americans. Yet its ...
August 7, 2018 — While heart failure is an uncommon complication of breast cancer treatment, the risk is higher in ...
New research shows superiority of Ultromics’ AI in predicting cardiac-related death As the use of artificial ...
July 17, 2018 — Medtronic plc recently received U.S. Food and Drug Administration (FDA) approval for a less-invasive ...
July 11, 2018 — French-based CorWave announced that its CALYPSO program has received 14 million euros to develop CorWave ...
Partho Sengupta, M.D., DM, FACC, FASE, chief division of cardiology, director of cardiac imaging, West Virginia ...
July 2, 2018 — University of Washington (UW) Medicine cardiologists have developed a tool to predict which heart failure ...
June 25, 2018 — New research finds changes in cellular struts called microtubules (MT) can affect the stiffness of ...
June 4, 2018 — The U.S. Food and Drug Administration said Medtronic initiated a Class 1 recall all 204,017 of its ...
May 30, 2018 — Data from the GENETIC-AF trial was presented in a “Late Breaking Clinical Trials” oral presentation at ...
May 23, 2018 — Abbott has initiated a Class I recall of the HeartMate 3 Left Ventricular Assist System due to a ...
May 22, 2018 — Medtronic plc announced study results showing its AdaptivCRT algorithm is associated with improved ...
May 18, 2018 — In a new study, cardiac contractility modulation (CCM) therapy was confirmed to significantly improve ...
May 16, 2018 — Israel-based V-Wave Ltd. recently closed a $70 million Series C financing for its proprietary, minimally ...
May 14, 2018 — Ancora Heart Inc. announced the expansion of the company’s U.S. feasibility study to evaluate the ...